Cargando…
Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192057/ https://www.ncbi.nlm.nih.gov/pubmed/33986128 http://dx.doi.org/10.1212/NXI.0000000000001009 |
| _version_ | 1783705979398914048 |
|---|---|
| author | Shambrook, Pauline Hesters, Adèle Marois, Clémence Zemba, Daniel Servan, Jérôme Gaymard, Bertrand Pico, Fernando Delorme, Cécile Lubetzki, Catherine Arnulf, Isabelle Psimaras, Dimitri Honnorat, Jérôme Gales, Ana Méneret, Aurélie |
| author_facet | Shambrook, Pauline Hesters, Adèle Marois, Clémence Zemba, Daniel Servan, Jérôme Gaymard, Bertrand Pico, Fernando Delorme, Cécile Lubetzki, Catherine Arnulf, Isabelle Psimaras, Dimitri Honnorat, Jérôme Gales, Ana Méneret, Aurélie |
| author_sort | Shambrook, Pauline |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8192057 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81920572021-06-11 Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease Shambrook, Pauline Hesters, Adèle Marois, Clémence Zemba, Daniel Servan, Jérôme Gaymard, Bertrand Pico, Fernando Delorme, Cécile Lubetzki, Catherine Arnulf, Isabelle Psimaras, Dimitri Honnorat, Jérôme Gales, Ana Méneret, Aurélie Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2021-05-11 /pmc/articles/PMC8192057/ /pubmed/33986128 http://dx.doi.org/10.1212/NXI.0000000000001009 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Clinical/Scientific Notes Shambrook, Pauline Hesters, Adèle Marois, Clémence Zemba, Daniel Servan, Jérôme Gaymard, Bertrand Pico, Fernando Delorme, Cécile Lubetzki, Catherine Arnulf, Isabelle Psimaras, Dimitri Honnorat, Jérôme Gales, Ana Méneret, Aurélie Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease |
| title | Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease |
| title_full | Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease |
| title_fullStr | Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease |
| title_full_unstemmed | Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease |
| title_short | Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease |
| title_sort | delayed benefit from aggressive immunotherapy in waxing and waning anti-iglon5 disease |
| topic | Clinical/Scientific Notes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192057/ https://www.ncbi.nlm.nih.gov/pubmed/33986128 http://dx.doi.org/10.1212/NXI.0000000000001009 |
| work_keys_str_mv | AT shambrookpauline delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT hestersadele delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT maroisclemence delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT zembadaniel delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT servanjerome delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT gaymardbertrand delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT picofernando delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT delormececile delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT lubetzkicatherine delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT arnulfisabelle delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT psimarasdimitri delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT honnoratjerome delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT galesana delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease AT meneretaurelie delayedbenefitfromaggressiveimmunotherapyinwaxingandwaningantiiglon5disease |